Home » WHO recommends the use of interleukin-6 receptor antagonists to treat new coronary pneumonia

WHO recommends the use of interleukin-6 receptor antagonists to treat new coronary pneumonia

by admin









</p> <p> WHO recommends the use of interleukin-6 receptor antagonists to treat new coronary pneumonia<br />

Home> News> eCompany

WHO recommends the use of interleukin-6 receptor antagonists to treat new coronary pneumonia

2021-07-07 06:22

Source: Securities Times

Securities Times

2021-07-07 06:22

Securities Times e company reported that on July 6, local time, the WHO updated the guidelines for the care of patients with new coronary pneumonia to include interleukin-6 receptor antagonists. The WHO claims that the drug can save the lives of severe and critically ill patients with new coronary pneumonia, and is particularly effective when used with corticosteroids. Studies have shown that compared with standard treatment, the use of the drug in severe or critically ill patients can reduce the chance of death by 13%. (CCTV News)

Disclaimer: The Securities Times strives for truthful and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. The operation is at your own risk.

  • Securities Times APP
  • WeChat public account


  • 3412499

    WHO recommends the use of interleukin-6 receptor antagonists to treat new coronary pneumonia

    6885

    e company

    news

    1429

    2021-07-07

    See also  Homes, the EU is preparing a tight fit on energy certification to make them more efficient

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy